-transparent.png){kind=logo}
A method was developed to induce and continuously monitor vasoocclusive crisis of sickle cell disease in non-human primates. Pentoxifylline, a phosphodiesterase inhibitory agent, showed significant preventive effect. This may be based on its ability to increase intracellular cAMP levels and consequently to decrease platelet aggregation and to increase red cell deformability.
Related Publications
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
May 2015,
AJR. American journal of roentgenology,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
May 2010,
The American journal of emergency medicine,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
July 2022,
American journal of respiratory and critical care medicine,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
February 2015,
Proceedings of the National Academy of Sciences of the United States of America,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
January 1998,
Journal of pediatric orthopedics,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
January 1989,
Pediatrie,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
January 2007,
Southern medical journal,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
January 2015,
Case reports in medicine,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
December 2010,
Blood cells, molecules & diseases,
J L Ambrus, and
C M Ambrus, and
H Gastpar, and
R Bannerman, and
R Bettigole, and
S Friedman
January 2022,
The Turkish journal of pediatrics,
